Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 2 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte MalignanciesRecruitingNCT07070323Phase 1/2
- A Study of CTD402 in T-ALL/LBL PatientsRecruitingNCT07070219Phase 1/2
- A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALLRecruitingNCT07066397Phase 1
- Femoral Arterial Cannulation in PediatricsRecruitingNCT07059624Not applicable
- Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALLRecruitingNCT07059156Phase 2/3
- Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)RecruitingNCT07053059Phase 2
- Online Physical Activity and Health Counseling for Survivors of Childhood Acute Lymphoblastic LeukemiaNot yet recruitingNCT07042932Not applicable
- Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"RecruitingNCT07021677Phase 2
- A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantRecruitingNCT07020533Phase 1
- Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic MalignanciesRecruitingNCT07016165Phase 4
- Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid MutationsRecruitingNCT07012447Phase 2
- BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALLRecruitingNCT07008885Phase 1/2
- Real World Asparaginase Therapy ToxicityNot yet recruitingNCT07008027
- Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT07003737Not applicable
- Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous LineageNot yet recruitingNCT06991920Not applicable
- Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline ChemotherapyRecruitingNCT06985485Phase 2
- Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)RecruitingNCT06956781Not applicable
- JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ LeukemiaRecruitingNCT06940960Not applicable
- Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALLNot yet recruitingNCT06930105Phase 2
- "Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALLRecruitingNCT06919393
- Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaRecruitingNCT06918431Phase 2
- Hepatoprotective for Children and Adolescent With Acute Lymphoblastic LeukemiaRecruitingNCT06918054Phase 4
- Co-Transplant of an Unmodified Haplo-Identical Graft With Cord BloodRecruitingNCT06904482Phase 2
- Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesRecruitingNCT06904066Phase 1
- A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell MalignanciesNot yet recruitingNCT06894693Phase 1
- Massage Impact on Sleep in Pediatric OncologyRecruitingNCT06892158Not applicable
- JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ LeukemiaRecruitingNCT06890065Not applicable
- Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALLRecruitingNCT06886074Phase 2
- Newly-diagnosed Low Risk Pediatric B-cell ALL ProtocolRecruitingNCT06882057Phase 2/3
- Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoringRecruitingNCT06867289Not applicable
- CD-19 CAR-T Cell for Pediatric ALL or LymphomaRecruitingNCT06866873Not applicable
- A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in ChildrenRecruitingNCT06861530
- Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCTNot yet recruitingNCT06861348Phase 2
- A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic LeukemiaRecruitingNCT06860269Phase 2/3
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationRecruitingNCT06859424Phase 2
- Newly-diagnosed Pediatric T-cell ALL ProtocolRecruitingNCT06855810Phase 2/3
- The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic LeukemiaNot yet recruitingNCT06849401Early Phase 1
- CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive LeukemiaRecruitingNCT06847269Phase 2
- Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute LeukemiaRecruitingNCT06845592Not applicable
- Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia SurvivorsRecruitingNCT06819475Not applicable
- Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute LeukemiaRecruitingNCT06816134Phase 2
- Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningRecruitingNCT06815003Phase 2
- Expanded Access Program for OOS Obe-celAvailableNCT06799221
- Little NIRVANA for Pediatric Pain and AnxietyEnrolling by invitationNCT06795126Not applicable
- Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06793241Early Phase 1
- Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)RecruitingNCT06785324Not applicable
- A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological TumorsRecruitingNCT06783816Not applicable
- CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic LeukemiaRecruitingNCT06777979Phase 1
- Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1Not yet recruitingNCT06777264Phase 2
- Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic LeukemiaEnrolling by invitationNCT06773936Phase 2
- Evaluation of Pediatric eCART ImplementationRecruitingNCT06771830Not applicable
- Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL ProtocolRecruitingNCT06764238Phase 2/3
- NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALLNot yet recruitingNCT06763302Not applicable
- Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with HemoblastosisRecruitingNCT06756152Phase 2/3
- Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic LeukemiaRecruitingNCT06756022
- Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALLRecruitingNCT06754267Phase 2
- CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.RecruitingNCT06752785Phase 1
- Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and LymphomaRecruitingNCT06747910Not applicable
- Role of Cbc Indices in Acute Lymphoblastic Leukemia PatientsNot yet recruitingNCT06746571Not applicable
- Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALLRecruitingNCT06742515Phase 2
- Allo-HSCT vs ASCT in Adult T-LBLNot yet recruitingNCT06741813Not applicable
- Hospital Based Continuous Patient Monitoring SystemNot yet recruitingNCT06739447Not applicable
- Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic LeukemiaRecruitingNCT06735690Early Phase 1
- CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic TumorsRecruitingNCT06735495Phase 1/2
- Virtual Reality-Infused Treadmill Training on Aging-Related OutcomesRecruitingNCT06727942Not applicable
- Virtual Reality During Lumbar Punctures in Acute Lymphoblastic LeukemiaRecruitingNCT06722638Not applicable
- An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative DisordersNot yet recruitingNCT06721598
- Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1RecruitingNCT06718244Phase 2
- Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young AdultsRecruitingNCT06709469Phase 1
- Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaRecruitingNCT06696833Early Phase 1
- Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University HospitalRecruitingNCT06681363
- Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic LeukemiaNot yet recruitingNCT06674850
- Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.RecruitingNCT06659653Early Phase 1
- Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationNot yet recruitingNCT06658938Not applicable
- Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALLNot yet recruitingNCT06658925Phase 2
- Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter StudyNot yet recruitingNCT06649422
- Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALLNot yet recruitingNCT06641024Phase 1
- Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALLRecruitingNCT06635330Phase 1/2
- Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALLRecruitingNCT06633354Early Phase 1
- Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphomaRecruitingNCT06633341Early Phase 1
- Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALLNot yet recruitingNCT06631040Phase 1/2
- Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic InterventionRecruitingNCT06626893Not applicable
- Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.RecruitingNCT06608732Phase 2
- Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic LeukemiaRecruitingNCT06608342Phase 2
- Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic LeukemiaRecruitingNCT06607419Phase 2/3
- BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.RecruitingNCT06598722Phase 2
- Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06581081Not applicable
- Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALLRecruitingNCT06578546Phase 2
- Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell TransplantRecruitingNCT06575296Phase 1
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06564545Phase 2
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06564493Phase 2
- Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with LeukemiaEnrolling by invitationNCT06560879Phase 2
- Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute LeukemiaNot yet recruitingNCT06559644Early Phase 1
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06559345Phase 2
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06557161Phase 2
- Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALLRecruitingNCT06554626Phase 2
- Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCTRecruitingNCT06551584Phase 1
- Breath Analysis for the Detection of Invasive Fungal InfectionsRecruitingNCT06537726
- Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and LymphomaRecruitingNCT06533748Phase 2
- Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in ChildrenRecruitingNCT06529575